Roth Capital, Oppenheimer, Janney Montgomery Scott to assist with sale
By Devika Patel
Knoxville, Tenn., Feb. 4 – Tonix Pharmaceuticals Holding Corp. said it priced a $28.67 million public sale of stock with a $4.3 million greenshoe. The offering was announced on Tuesday.
The company will sell 4.9 million common shares at $5.85 per share. The price per share is a 3.47% discount to the Feb. 3 closing share price of $6.06.
Roth Capital Partners and Oppenheimer & Co. are the bookrunning managers.
Settlement is expected on Feb. 9.
Proceeds will be used for development, working capital and other general corporate purposes.
Tonix is a specialty pharmaceutical company based in Zurich.
| Issuer: | Tonix Pharmaceuticals Holding Corp.
|
| Issue: | Common stock
|
| Amount: | $28,665,000
|
| Greenshoe: | $4,299,750
|
| Shares: | 4.9 million
|
| Price: | $5.85
|
| Warrants: | No
|
| Bookrunners: | Roth Capital Partners and Oppenheimer & Co.
|
| Co-manager: | Janney Montgomery Scott
|
| Announcement date: | Feb. 3
|
| Pricing date: | Feb. 4
|
| Settlement date: | Feb. 9
|
| Stock symbol: | Nasdaq: TNXP
|
| Stock price: | $6.06 at close Feb. 3
|
| Market capitalization: | $63.33 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
